KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 160 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $276,000 | -8.3% | 47,017 | -16.9% | 0.06% | -9.7% |
Q3 2016 | $301,000 | -19.7% | 56,593 | 0.0% | 0.06% | -19.5% |
Q2 2016 | $375,000 | +42.0% | 56,593 | +0.0% | 0.08% | +37.5% |
Q1 2016 | $264,000 | -7.7% | 56,588 | 0.0% | 0.06% | -11.1% |
Q4 2015 | $286,000 | +43.7% | 56,588 | 0.0% | 0.06% | +40.0% |
Q3 2015 | $199,000 | -64.8% | 56,588 | 0.0% | 0.04% | -57.5% |
Q2 2015 | $565,000 | -21.5% | 56,588 | 0.0% | 0.11% | -20.9% |
Q1 2015 | $720,000 | – | 56,588 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |